Deborah E. Fishman is a partner at Arnold & Porter Kaye Scholer LLP, who focuses on representing biopharmaceutical and medical device companies in IP and commercial disputes.
As a leader in life sciences litigation, she serves as an editor of ABA's Patent Litigation Strategies Handbook and authors the chapters on biotechnology and biosimilar patent litigation.
"The life sciences field is going gangbusters, ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In